The global human embryonic stem cells market size is
anticipated to reach USD 1.06 billion by 2025, according to a new report by
Grand View Research, Inc. Application of hESCs as a promising donor source for
cellular transplantation therapies is anticipated to bolster progress through
to 2025. hESCs technology tends to be useful for tissue engineering in humans
due to high histocompatibility between host and graft.
Maintenance of developmental potential for
contribution of derivatives of all three germ layers is an important feature of
these cells. This ability remains consistent even after clonal derivation or
prolonged undifferentiated proliferation, thus pronouncing its accelerated
uptake.
In addition, these are capable in expressing
high level of alkaline phosphatase, key transcription factors, and telomerase.
These factors are found to be of great importance in the maintenance of the
inner cellular mass pluripotency.
Furthermore, hESCs can be easily
differentiated into defined neurons, neural lineages, oligodendrocytes, and
astrocytes. Aforementioned characteristic makes it useful in studying the
sequence of events that take place during early neurodevelopment.
However, use of stem cells derived from viable
embryos is fraught with ethical issues, prompting scientists to explore other
methods to generate ESCs. The other methods include derivation of embryonic
germ cells, stem cells from dead embryos, and other techniques.
Browse full research report on Human
Embryonic Stem Cells Market:
https://www.grandviewresearch.com/industry-analysis/human-embryonic-stem-cell-market
Further Key
Findings from the Report Suggest:
- hESC derivation provides a unique opportunity
for early human development studies
- It is believed to hold a substantial potential
for regenerative medicine and biopharma
- Differentiated derivatives of these cells are
applicable for screening assays in development of novel pharmaceutical
moieties
- Screening for mutagenic as well as toxic
compounds can also be carried out using such derivatives
- Presence of lack of suitable donor organs and
tissues for regenerative medicine is expected to increase the demand thus
influencing growth
- Stem cell research is anticipated to exhibit
fastest growth amongst the other applications
- However, presence of controversies pertaining
to their use as a consequence of ethical considerations is responsible for
steady growth
- Europe accounts for considerable share of the
market, following North America
- As per a recent survey carried out by Swiss
government, citizens there are more willing to accept embryonic stem cell
research than politicians
- Asia Pacific is anticipated to drive market
with fastest YoY growth
- Rising awareness amongst the population and
physicians with respect to associated therapies is anticipated to propel
progress
- Key players contributing in this market are
CellGenix GmbH, International Stem Cell Corporation, Thermo Fisher
Scientific, Inc.; Kite Pharma, PromoCell GmbH, and Lonza
- Presence of clinical trial pipeline for
embryonic stem cell derived therapy for targeting different diseases is
expected to fuel growth.
- The diseases targeted include macular
degeneration, Parkinson’s disease, type I diabetes mellitus, and spinal
cord injury.
Browse request sample of this report by
Grand View Research: https://www.grandviewresearch.com/industry-analysis/human-embryonic-stem-cell-market/request/rs1
Grand
View Research has segmented the human embryonic stem cells market on the basis
of application and region:
Human
Embryonic Stem Cells Application Outlook (Revenue, USD Million,
2014 - 2025)
- Regenerative
medicine
- Stem cell biology
research
- Tissue engineering
- Toxicology testing
Human
Embryonic Stem Cells Regional Outlook (Revenue, USD Million,
2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Middle East and
Africa (MEA)
- South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment